173 related articles for article (PubMed ID: 33687857)
1. Another oral antiviral treatment, but still far away from hepatitis B virus cure.
Tseng TC
Clin Mol Hepatol; 2021 Apr; 27(2):281-282. PubMed ID: 33687857
[No Abstract] [Full Text] [Related]
2. Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
Ahn SH; Kim W; Jung YK; Yang JM; Jang JY; Kweon YO; Cho YK; Kim YJ; Hong GY; Kim DJ; Um SH; Sohn JH; Lee JW; Park SJ; Lee BS; Kim JH; Kim HS; Yoon SK; Kim MY; Yim HJ; Lee KS; Lim YS; Lee WS; Park NH; Jin SY; Kim KH; Choi W; Han KH
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1850-1859.e4. PubMed ID: 30448598
[TBL] [Abstract][Full Text] [Related]
3. Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B.
Song JE; Park JY
Expert Opin Pharmacother; 2021 Dec; 22(18):2427-2433. PubMed ID: 34392744
[TBL] [Abstract][Full Text] [Related]
4. Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
Jung CY; Kim HW; Lee JI; Lee HW; Ahn SH; Kim SU; Kim BS
Liver Int; 2022 Nov; 42(11):2408-2417. PubMed ID: 35943853
[TBL] [Abstract][Full Text] [Related]
5. Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go.
Lampertico P
Gut; 2014 Jun; 63(6):869-70. PubMed ID: 24162592
[No Abstract] [Full Text] [Related]
6. Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B.
Jung YW; Kim M; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SU
J Korean Med Sci; 2020 May; 35(17):e104. PubMed ID: 32356416
[TBL] [Abstract][Full Text] [Related]
7. Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study.
Yuen MF; Ahn SH; Lee KS; Um SH; Cho M; Yoon SK; Lee JW; Park NH; Kweon YO; Sohn JH; Lee J; Kim JA; Lai CL; Han KH
J Hepatol; 2015 Mar; 62(3):526-32. PubMed ID: 25450709
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus with primary resistance to adefovir.
Chang TT; Lai CL
N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
[No Abstract] [Full Text] [Related]
11. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Janssen HL; Sonneveld MJ; Brunetto MR
Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
[No Abstract] [Full Text] [Related]
12. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Park JG; Park SY
Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
[TBL] [Abstract][Full Text] [Related]
13. [Recent therapies for hepatitis B (discussion)].
Tanaka E; Suzuki F; Tanaka Y; Shiryu H
Nihon Shokakibyo Gakkai Zasshi; 2007 Oct; 104(10):1465-79. PubMed ID: 17917394
[No Abstract] [Full Text] [Related]
14. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
Mohamadnejad M
Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
[No Abstract] [Full Text] [Related]
15. Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.
Höner Zu Siederdissen C; Hui AJ; Sukeepaisarnjaroen W; Tangkijvanich P; Su WW; Nieto GEG; Gineste P; Nitcheu J; Crabé S; Stepien S; Manns MP; Trépo C; Wedemeyer H; Cornberg M
J Infect Dis; 2018 Sep; 218(9):1480-1484. PubMed ID: 29893893
[TBL] [Abstract][Full Text] [Related]
16. Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue.
Lee SW; Kim SU
Aliment Pharmacol Ther; 2020 Sep; 52(5):889-890. PubMed ID: 32852818
[No Abstract] [Full Text] [Related]
17. Head-To-Head Comparison of Two Years Efficacy of Entecavir and Tenofovir in Patients with Treatment-Naïve Chronic Hepatitis B--The Real Life Data.
Hepatogastroenterology; 2015 Jun; 62(140):982-6. PubMed ID: 26902041
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
Doğan ÜB; Kara B; Gümürdülü Y; Soylu A; Akin MS
Turk J Gastroenterol; 2012 Jun; 23(3):247-52. PubMed ID: 22798114
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
Yang F; Wu XF; Wei N
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
[No Abstract] [Full Text] [Related]
20. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.
Kim SU; Seo YS; Lee HA; Kim MN; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Hwang SG; Rim KS; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
J Hepatol; 2019 Sep; 71(3):456-464. PubMed ID: 30959156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
